Coenzyme Q10 as an adjunctive strategy to reduce paclitaxel-induced toxicities in breast cancer: a randomized controlled trial.

BMC Pharmacol Toxicol · 2026 · PMC13339401 · PMID 42401951

Europe PMC DOI

hedged sentence

0.3290

closest p · 6.6× alpha

0.3290

boldest claim

The sentences

a numerical trendp = 0.329not close (p > 0.1)

Although this difference showed a numerical trend favoring CoQ10, it did not reach statistical significance ( p = 0.329) as shown Supplementary file 3 Table 17.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.